AGP
ABBV icon

Aspire Growth Partners’s AbbVie ABBV Stock Holding History

Aspire Growth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$561K Sell
2,578
-23
-0.9% -$5.1K 0.38% 57
2025
Q4 		$594K Buy
2,601
+17
+0.7% +$3.87K 0.41% 57
2025
Q3 		$598K Sell
2,584
-110
-4% -$22.4K 0.44% 55
2025
Q2 		$500K Sell
2,694
-33
-1% -$6.13K 0.41% 59
2025
Q1 		$513K Sell
2,727
-12
-0.4% -$2.33K 0.46% 59
2024
Q4 		$487K Buy
+2,739
New +$504K 0.48% 57

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aspire Growth Partners's ABBV Position: Q1 2026 in Review

Aspire Growth Partners reduced its AbbVie (ABBV) stake by 0.88% in Q1 2026, selling an estimated $5.1K and leaving 2,578 shares worth $561K. The position accounts for 0.38% of the portfolio, ranked #57.

Aspire Growth Partners first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $598K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Aspire Growth Partners held 2,578 shares of AbbVie worth $561K as of Q1 2026.
  • Aspire Growth Partners sold 23 AbbVie shares in Q1 2026, an estimated $5.1K.
  • AbbVie made up 0.38% of Aspire Growth Partners's portfolio in Q1 2026, its #57 holding.
  • Aspire Growth Partners first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Aspire Growth Partners's AbbVie position peaked at $598K in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Aspire Growth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.